Researchers have shown that a dried drop of fingertip blood—collected via a simple finger-prick—can reveal biomarkers associated with Alzheimer’s disease, offering a less invasive, more accessible route to early diagnosis. Improving and validating blood-based tests remains a key research challenge to ensure sensitivity, specificity and clinical applicability compared with current invasive or costly methods.